Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

NCT04524390 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Atresia

Interventions

DRUG: Maralixibat
OTHER: Placebo

Sponsor

Mirum Pharmaceuticals, Inc.